ID   UBP28_HUMAN             Reviewed;        1077 AA.
AC   Q96RU2; B0YJC0; B0YJC1; Q6NZX9; Q9P213;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   15-MAR-2017, entry version 148.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 28;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 28;
DE   AltName: Full=Ubiquitin thioesterase 28;
DE   AltName: Full=Ubiquitin-specific-processing protease 28;
GN   Name=USP28; Synonyms=KIAA1515;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=11597335; DOI=10.1186/gb-2001-2-10-research0043;
RA   Valero R., Bayes M., Francisca Sanchez-Font M., Gonzalez-Angulo O.,
RA   Gonzalez-Duarte R., Marfany G.;
RT   "Characterization of alternatively spliced products and tissue-
RT   specific isoforms of USP28 and USP25.";
RL   Genome Biol. 2:RESEARCH0043.1-RESEARCH0043.10(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 289-1077 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=10819331; DOI=10.1093/dnares/7.2.143;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:143-150(2000).
RN   [7]
RP   FUNCTION, INTERACTION WITH TP53BP1, PHOSPHORYLATION AT SER-67 AND
RP   SER-714, AND MUTAGENESIS OF CYS-171.
RX   PubMed=16901786; DOI=10.1016/j.cell.2006.06.039;
RA   Zhang D., Zaugg K., Mak T.W., Elledge S.J.;
RT   "A role for the deubiquitinating enzyme USP28 in control of the DNA-
RT   damage response.";
RL   Cell 126:529-542(2006).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH FBXW7.
RX   PubMed=17873522; DOI=10.4161/cc.6.19.4804;
RA   Popov N., Herold S., Llamazares M., Schulein C., Eilers M.;
RT   "Fbw7 and Usp28 regulate myc protein stability in response to DNA
RT   damage.";
RL   Cell Cycle 6:2327-2331(2007).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH FBXW7, AND
RP   MUTAGENESIS OF CYS-171.
RX   PubMed=17558397; DOI=10.1038/ncb1601;
RA   Popov N., Wanzel M., Madiredjo M., Zhang D., Beijersbergen R.,
RA   Bernards R., Moll R., Elledge S.J., Eilers M.;
RT   "The ubiquitin-specific protease USP28 is required for MYC
RT   stability.";
RL   Nat. Cell Biol. 9:765-774(2007).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [11]
RP   FUNCTION.
RX   PubMed=18662541; DOI=10.1016/j.cell.2008.05.043;
RA   Bassermann F., Frescas D., Guardavaccaro D., Busino L.,
RA   Peschiaroli A., Pagano M.;
RT   "The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response
RT   checkpoint.";
RL   Cell 134:256-267(2008).
RN   [12]
RP   DEGRADATION, AND INDUCTION.
RX   PubMed=20046830; DOI=10.1371/journal.pone.0008531;
RA   Li Q., Kluz T., Sun H., Costa M.;
RT   "Mechanisms of c-myc degradation by nickel compounds and hypoxia.";
RL   PLoS ONE 4:E8531-E8531(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   FUNCTION, INTERACTION WITH PRKD1 AND ZNF304, PHOSPHORYLATION,
RP   MUTAGENESIS OF CYS-171 AND SER-899, AND INDUCTION.
RX   PubMed=24623306; DOI=10.7554/eLife.02313;
RA   Serra R.W., Fang M., Park S.M., Hutchinson L., Green M.R.;
RT   "A KRAS-directed transcriptional silencing pathway that mediates the
RT   CpG island methylator phenotype.";
RL   Elife 3:E02313-E02313(2014).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1048, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   STRUCTURE BY NMR OF 22-132.
RG   Northeast structural genomics consortium (NESG);
RT   "NMR solution structure of the N-terminal domain of human USP28.";
RL   Submitted (JUL-2012) to the PDB data bank.
CC   -!- FUNCTION: Deubiquitinase involved in DNA damage response
CC       checkpoint and MYC proto-oncogene stability. Involved in DNA
CC       damage induced apoptosis by specifically deubiquitinating proteins
CC       of the DNA damage pathway such as CLSPN. Also involved in G2 DNA
CC       damage checkpoint, by deubiquitinating CLSPN, and preventing its
CC       degradation by the anaphase promoting complex/cyclosome (APC/C).
CC       In contrast, it does not deubiquitinate PLK1. Specifically
CC       deubiquitinates MYC in the nucleoplasm, leading to prevent MYC
CC       degradation by the proteasome: acts by specifically interacting
CC       with isoform 1 of FBXW7 (FBW7alpha) in the nucleoplasm and
CC       counteracting ubiquitination of MYC by the SCF(FBW7) complex. In
CC       contrast, it does not interact with isoform 4 of FBXW7 (FBW7gamma)
CC       in the nucleolus, allowing MYC degradation and explaining the
CC       selective MYC degradation in the nucleolus. Deubiquitinates
CC       ZNF304, hence preventing ZNF304 degradation by the proteasome and
CC       leading to the activated KRAS-mediated promoter hypermethylation
CC       and transcriptional silencing of tumor suppressor genes (TSGs) in
CC       a subset of colorectal cancers (CRC) cells (PubMed:24623306).
CC       {ECO:0000269|PubMed:16901786, ECO:0000269|PubMed:17558397,
CC       ECO:0000269|PubMed:17873522, ECO:0000269|PubMed:18662541,
CC       ECO:0000269|PubMed:24623306}.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC   -!- SUBUNIT: Interacts with ZNF304 (PubMed:24623306). Interacts with
CC       PRKD1 (PubMed:24623306). Interacts with TP53BP1 (PubMed:16901786).
CC       Interacts with isoform 1 of FBXW7; following DNA damage,
CC       dissociates from FBXW7 leading to degradation of MYC
CC       (PubMed:17873522, PubMed:17558397) (PubMed:17873522).
CC       {ECO:0000269|PubMed:16901786, ECO:0000269|PubMed:17558397,
CC       ECO:0000269|PubMed:17873522, ECO:0000269|PubMed:24623306}.
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:17558397}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q96RU2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96RU2-2; Sequence=VSP_015580;
CC       Name=3;
CC         IsoId=Q96RU2-3; Sequence=VSP_057359, VSP_057360;
CC         Note=No experimental confirmation available.;
CC   -!- INDUCTION: Down-regulated upon hypoxia (PubMed:20046830). Up-
CC       regulated by the transcription factor c-Jun/JUN in a KRAS-
CC       dependent manner in colorectal cancer (CRC) cells
CC       (PubMed:24623306). {ECO:0000269|PubMed:20046830,
CC       ECO:0000269|PubMed:24623306}.
CC   -!- PTM: Degradaded upon nickel ion level or hypoxia exposure.
CC   -!- PTM: Phosphorylated upon DNA damage at Ser-67 and Ser-714, by ATM
CC       or ATR (PubMed:16901786). Phosphorylated by PRKD1
CC       (PubMed:24623306). {ECO:0000269|PubMed:16901786,
CC       ECO:0000269|PubMed:24623306}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. USP28 subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF266283; AAK58565.1; -; mRNA.
DR   EMBL; EF445045; ACA06098.1; -; Genomic_DNA.
DR   EMBL; EF445045; ACA06099.1; -; Genomic_DNA.
DR   EMBL; AP001874; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003170; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455523; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF459544; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471065; EAW67232.1; -; Genomic_DNA.
DR   EMBL; BC065928; AAH65928.1; -; mRNA.
DR   EMBL; AB040948; BAA96039.1; -; mRNA.
DR   CCDS; CCDS31680.1; -. [Q96RU2-1]
DR   RefSeq; NP_001333187.1; NM_001346258.1. [Q96RU2-2]
DR   RefSeq; NP_001333202.1; NM_001346273.1. [Q96RU2-3]
DR   RefSeq; NP_065937.1; NM_020886.3. [Q96RU2-1]
DR   UniGene; Hs.503891; -.
DR   PDB; 2LVA; NMR; -; A=22-132.
DR   PDB; 2MUU; NMR; -; A=1-120.
DR   PDBsum; 2LVA; -.
DR   PDBsum; 2MUU; -.
DR   ProteinModelPortal; Q96RU2; -.
DR   SMR; Q96RU2; -.
DR   BioGrid; 121683; 57.
DR   IntAct; Q96RU2; 11.
DR   MINT; MINT-8415329; -.
DR   STRING; 9606.ENSP00000003302; -.
DR   ChEMBL; CHEMBL2157853; -.
DR   MEROPS; C19.054; -.
DR   iPTMnet; Q96RU2; -.
DR   PhosphoSitePlus; Q96RU2; -.
DR   BioMuta; USP28; -.
DR   DMDM; 20140700; -.
DR   EPD; Q96RU2; -.
DR   MaxQB; Q96RU2; -.
DR   PaxDb; Q96RU2; -.
DR   PeptideAtlas; Q96RU2; -.
DR   PRIDE; Q96RU2; -.
DR   Ensembl; ENST00000003302; ENSP00000003302; ENSG00000048028. [Q96RU2-1]
DR   Ensembl; ENST00000537706; ENSP00000445743; ENSG00000048028. [Q96RU2-3]
DR   GeneID; 57646; -.
DR   KEGG; hsa:57646; -.
DR   UCSC; uc001poh.4; human. [Q96RU2-1]
DR   CTD; 57646; -.
DR   DisGeNET; 57646; -.
DR   GeneCards; USP28; -.
DR   HGNC; HGNC:12625; USP28.
DR   HPA; HPA006778; -.
DR   HPA; HPA006779; -.
DR   MIM; 610748; gene.
DR   neXtProt; NX_Q96RU2; -.
DR   OpenTargets; ENSG00000048028; -.
DR   PharmGKB; PA37250; -.
DR   eggNOG; KOG1863; Eukaryota.
DR   eggNOG; COG5077; LUCA.
DR   GeneTree; ENSGT00390000016082; -.
DR   HOGENOM; HOG000007956; -.
DR   HOVERGEN; HBG056030; -.
DR   InParanoid; Q96RU2; -.
DR   KO; K21122; -.
DR   OMA; CIASTTQ; -.
DR   OrthoDB; EOG091G00QR; -.
DR   PhylomeDB; Q96RU2; -.
DR   TreeFam; TF329035; -.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   SIGNOR; Q96RU2; -.
DR   ChiTaRS; USP28; human.
DR   GenomeRNAi; 57646; -.
DR   PRO; PR:Q96RU2; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000048028; -.
DR   CleanEx; HS_USP28; -.
DR   ExpressionAtlas; Q96RU2; baseline and differential.
DR   Genevisible; Q96RU2; HS.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0043234; C:protein complex; IDA:UniProtKB.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; TAS:Reactome.
DR   GO; GO:0008283; P:cell proliferation; IMP:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0034644; P:cellular response to UV; IDA:UniProtKB.
DR   GO; GO:0000077; P:DNA damage checkpoint; IMP:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; IDA:UniProtKB.
DR   GO; GO:0007265; P:Ras protein signal transduction; IMP:UniProtKB.
DR   GO; GO:0031647; P:regulation of protein stability; IMP:UniProtKB.
DR   GO; GO:0010212; P:response to ionizing radiation; IDA:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR009060; UBA-like.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   Pfam; PF00443; UCH; 1.
DR   SUPFAM; SSF46934; SSF46934; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; DNA damage;
KW   DNA repair; Hydrolase; Nucleus; Phosphoprotein; Protease;
KW   Reference proteome; Thiol protease; Ubl conjugation pathway.
FT   CHAIN         1   1077       Ubiquitin carboxyl-terminal hydrolase 28.
FT                                /FTId=PRO_0000080657.
FT   DOMAIN       97    116       UIM. {ECO:0000305}.
FT   DOMAIN      162    650       USP.
FT   ACT_SITE    171    171       Nucleophile.
FT   ACT_SITE    600    600       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   MOD_RES      67     67       Phosphoserine.
FT                                {ECO:0000269|PubMed:16901786}.
FT   MOD_RES     375    375       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     550    550       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5I043}.
FT   MOD_RES     714    714       Phosphoserine.
FT                                {ECO:0000269|PubMed:16901786}.
FT   MOD_RES    1048   1048       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ     583    583       P -> E (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_057359.
FT   VAR_SEQ     584   1077       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_057360.
FT   VAR_SEQ     769    800       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10819331}.
FT                                /FTId=VSP_015580.
FT   MUTAGEN     171    171       C->A: Abolishes deubiquitinase activity.
FT                                {ECO:0000269|PubMed:16901786,
FT                                ECO:0000269|PubMed:17558397,
FT                                ECO:0000269|PubMed:24623306}.
FT   MUTAGEN     899    899       S->A: Prevents ZNF304 ubiquitination
FT                                reduction. {ECO:0000269|PubMed:24623306}.
FT   CONFLICT    289    303       VQLFYGTFLTEGVRE -> IVIVMSFLKSLSLCL (in
FT                                Ref. 4; BAA96039). {ECO:0000305}.
FT   HELIX         7      9       {ECO:0000244|PDB:2MUU}.
FT   HELIX        23     32       {ECO:0000244|PDB:2LVA}.
FT   HELIX        37     46       {ECO:0000244|PDB:2LVA}.
FT   TURN         47     49       {ECO:0000244|PDB:2LVA}.
FT   HELIX        51     58       {ECO:0000244|PDB:2LVA}.
FT   HELIX        60     63       {ECO:0000244|PDB:2LVA}.
FT   STRAND       71     73       {ECO:0000244|PDB:2MUU}.
FT   TURN         84     86       {ECO:0000244|PDB:2MUU}.
FT   STRAND       95     97       {ECO:0000244|PDB:2MUU}.
FT   HELIX       100    111       {ECO:0000244|PDB:2LVA}.
FT   HELIX       121    123       {ECO:0000244|PDB:2LVA}.
SQ   SEQUENCE   1077 AA;  122491 MW;  799C758888C67B82 CRC64;
     MTAELQQDDA AGAADGHGSS CQMLLNQLRE ITGIQDPSFL HEALKASNGD ITQAVSLLTD
     ERVKEPSQDT VATEPSEVEG SAANKEVLAK VIDLTHDNKD DLQAAIALSL LESPKIQADG
     RDLNRMHEAT SAETKRSKRK RCEVWGENPN PNDWRRVDGW PVGLKNVGNT CWFSAVIQSL
     FQLPEFRRLV LSYSLPQNVL ENCRSHTEKR NIMFMQELQY LFALMMGSNR KFVDPSAALD
     LLKGAFRSSE EQQQDVSEFT HKLLDWLEDA FQLAVNVNSP RNKSENPMVQ LFYGTFLTEG
     VREGKPFCNN ETFGQYPLQV NGYRNLDECL EGAMVEGDVE LLPSDHSVKY GQERWFTKLP
     PVLTFELSRF EFNQSLGQPE KIHNKLEFPQ IIYMDRYMYR SKELIRNKRE CIRKLKEEIK
     ILQQKLERYV KYGSGPARFP LPDMLKYVIE FASTKPASES CPPESDTHMT LPLSSVHCSV
     SDQTSKESTS TESSSQDVES TFSSPEDSLP KSKPLTSSRS SMEMPSQPAP RTVTDEEINF
     VKTCLQRWRS EIEQDIQDLK TCIASTTQTI EQMYCDPLLR QVPYRLHAVL VHEGQANAGH
     YWAYIYNQPR QSWLKYNDIS VTESSWEEVE RDSYGGLRNV SAYCLMYIND KLPYFNAEAA
     PTESDQMSEV EALSVELKHY IQEDNWRFEQ EVEEWEEEQS CKIPQMESST NSSSQDYSTS
     QEPSVASSHG VRCLSSEHAV IVKEQTAQAI ANTARAYEKS GVEAALSEVM LSPAMQGVIL
     AIAKARQTFD RDGSEAGLIK AFHEEYSRLY QLAKETPTSH SDPRLQHVLV YFFQNEAPKR
     VVERTLLEQF ADKNLSYDER SISIMKVAQA KLKEIGPDDM NMEEYKKWHE DYSLFRKVSV
     YLLTGLELYQ KGKYQEALSY LVYAYQSNAA LLMKGPRRGV KESVIALYRR KCLLELNAKA
     ASLFETNDDH SVTEGINVMN ELIIPCIHLI INNDISKDDL DAIEVMRNHW CSYLGQDIAE
     NLQLCLGEFL PRLLDPSAEI IVLKEPPTIR PNSPYDLCSR FAAVMESIQG VSTVTVK
//
